Results 31 to 40 of about 67,015 (304)

Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy. [PDF]

, 2012
Background The role of a tailored surgical approach for hypertrophic cardiomyopathy (HCM) on regional ventricular remodelling remains unknown. The aims of this study were to evaluate the pattern, extent and functional impact of regional ventricular ...
Cecchi, F, El Guindy, A, El-Hamamsy, I, Lekadir, K, Merrifield, R, Olivotto, I, Rega, L, Yacoub, MH, Yang, G   +8 more
core   +2 more sources

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM. [PDF]

, 2017
Hypertrophic cardiomyopathy (HCM) is a common disease in pet cats, affecting 10-15% of the pet cat population. The similarity to human HCM, the rapid progression of disease, and the defined and readily determined endpoints of feline HCM make it an ...
Freeman, Lisa M, Huggins, Gordon S, Maron, Martin S, Rush, John E, Stern, Joshua A   +4 more
core   +2 more sources

Clinical efficacy of CARTOSound-guided radiofrequency ablation for hypertrophic obstructive cardiomyopathy

Di-san junyi daxue xuebao, 2021
Objective To investigate the clinical efficacy of CARTOSound-guided radiofrequency ablation on hypertrophic obstructive cardiomyopathy. Methods The consecutive patients with hypertrophic obstructive cardiomyopathy accompanied with systolic anterior ...
JIANG Zhouqin, SHU Maoqin, CHAI Hong, DENG Shengrong, CHEN Xinghua, GAO Hao, ZHOU Yang   +6 more
doaj   +1 more source

Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023
Background Prior national data showed a substantial in‐hospital mortality in septal myectomy (SM) with an inverse volume–outcomes relationship. This study sought to assess the contemporary outcomes of septal reduction therapy and volume–outcome ...
Ahmed M A Altibi, F. Ghanem, Yuanzi Zhao, Miriam R. Elman, J. Cigarroa, B. Nazer, Howard K Song, Ahmad Masri   +7 more
semanticscholar   +1 more source

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY

Российский кардиологический журнал, 2015
Aim. To evaluate the prevalence of the left ventricle remodeling types in hypertrophic non-obstructive cardiomyopathy, and their relation to clinical and instrumental data. Material and methods.
D. V. Bogdanov
doaj   +1 more source

Collagen Cross‐Linking Is Associated With Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Collagen cross‐linking is covalent bonds among collagen fibers from catalysis of lysyl oxidase (LOX) and advanced glycation end products (AGEs).
Xuanye Bi, Yanyan Song, Yunhu Song, Jiansong Yuan, Jingang Cui, Shihua Zhao, Shubin Qiao   +6 more
doaj   +1 more source

Modern Perspectives on Hypertrophic Cardiomyopathy—No One Size Fits All [PDF]

Texas Heart Institute Journal
Despite substantial advances in the management of hypertrophic cardiomyopathy, advanced heart failure remains a major cause of morbidity in this patient population.
Brett Doliner, MD, Hadeel Gaddar, BS, Ramsey Kalil, MD, Alexander Postalian, MD   +3 more
doaj   +1 more source

A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor [PDF]

, 2018
RATIONALE: Catecholamine-producing tumors are rare, occurring in less than 0.2% of patients with hypertension, but can have relevant cardiovascular morbidity and mortality. PATIENT CONCERNS: A 37-year-old woman presented with a history of dyspnea, chest
Bisogni, Valeria, Bonvicini, Maria, Ciardi, Antonio, Concistré, Antonio, De Toma, Giorgio, Frustaci, Andrea, Iannucci, Gino, Letizia, Claudio, Mezzadri, Martina, Oliviero, Gaia, Olmati, Federica, Petramala, Luigi, Saracino, Vincenza   +12 more
core   +1 more source

Doubly Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2013
![Figure][1] [![Graphic][3] ][3][![Graphic][4] ][4] A 40-year-old woman with hypertrophic cardiomyopathy presented with New York Heart Association functional class III dyspnea and angina despite optimal medical therapy. Left heart catheterization with a high-fidelity,
Geske, Jeffrey B., Scantlebury, Dawn C., Nishimura, Rick A.   +2 more
openaire   +2 more sources

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy

Journal of Clinical Medicine, 2023
Background: Although disopyramide has been widely used to reduce left ventricular outflow obstruction (LVOTO) and to improve symptoms in patients with obstructive hypertrophic cardiomyopathy (oHCM), its use in real world as well as patient ...
N. Maurizi, C. Chiriatti, C. Fumagalli, M. Targetti, S. Passantino, Panagiotis Antiochos, Ioannis Skalidis, C. Chiti, G. Biagioni, A. Tomberli, S. Giovani, R. Coppini, F. Cecchi, I. Olivotto   +13 more
semanticscholar   +1 more source